These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23998981)

  • 21. Nutritional consequences of long-term acid suppression; are they clinically important?
    Johnson DA
    Curr Opin Gastroenterol; 2016 Mar; 32(2):136-40. PubMed ID: 26760397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proton pump inhibitors and their effect on the bone].
    Ječmenová M; Kroupa R
    Vnitr Lek; 2016 Feb; 62(2):139-46. PubMed ID: 27172441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the precautions with proton pump inhibitor use for reflux disease?
    Mospan CM
    JAAPA; 2015 Dec; 28(12):23-6. PubMed ID: 26595692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
    Kushner PR; Peura DA
    Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
    Tjon JA; Pe M; Soscia J; Mahant S
    Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Refractory gastroesophageal reflux disease (GERD) and PPI safety].
    Huerta-Iga FM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041
    [No Abstract]   [Full Text] [Related]  

  • 29. Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
    Heidelbaugh JJ; Metz DC; Yang YX
    Int J Clin Pract; 2012 Jun; 66(6):582-91. PubMed ID: 22607510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic use of proton pump inhibitors: is the risk of osteoporosis and fractures real?].
    Martí-Cabrera M; Martí-Masanet M; Esplugues JV
    Gastroenterol Hepatol; 2011 Apr; 34(4):271-7. PubMed ID: 21419526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
    Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
    Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse effects of proton pump inhibitors.
    Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?
    Çelebi A; Yılmaz H
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S68-S70. PubMed ID: 29199172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton Pump Inhibitors and Bone Health: What the Orthopaedic Surgeon Needs to Know.
    Wagner SC
    JBJS Rev; 2018 Dec; 6(12):e6. PubMed ID: 30562209
    [No Abstract]   [Full Text] [Related]  

  • 35. A benefit-risk assessment of the use of proton pump inhibitors in the elderly.
    Masclee GM; Sturkenboom MC; Kuipers EJ
    Drugs Aging; 2014 Apr; 31(4):263-82. PubMed ID: 24634248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
    Thurber KM; Otto AO; Stricker SL
    Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
    Hatemi İ; Esatoğlu SN
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S57-S60. PubMed ID: 29199170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When is proton pump inhibitor use appropriate?
    Yadlapati R; Kahrilas PJ
    BMC Med; 2017 Feb; 15(1):36. PubMed ID: 28219434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.